http://www.fpnotebook.com/
Dyspepsia
Aka: Dyspepsia, Nonulcer Dyspepsia, Functional Dyspepsia, Gastritis, Duodenitis, Acid-Related Dyspepsia- See Also
- Definition
- Chronic or recurrent Epigastric Pain
- Epidemiology
- Dyspepsia overall Prevalence: 40% of adults in U.S
- Causes
- Pathophysiology
- Unclear etiology, however may be related to altered gastric motility
- Helicobacter Pylori often found in patients with Dyspepsia, but causality is not clear
- Symptoms
- Epigastric burning
- Early satiety
- Associated symptoms
- Abdominal bloating (difficult to treat)
- Belching and Flatulence
- Nausea and Vomiting
- Halitosis
- Diagnosis: Rome III Criteria
- Symptoms for at least 12 weeks of the last 12 months
- No evidence for structural disease (including on upper endoscopy) that could explain symptoms and
- Symptom criteria (at least one is present)
- Epigastric Pain
- Epigastric burning
- Early satiety
- Bothersome postprandial fullness
- Differential Diagnosis
- See Dyspepsia Causes
- Approach: Step 1 - Consider differential Diagnosis
- See Dyspepsia Causes
- See Medication Causes of Dyspepsia
- Most common conditions in differential diagnosis
- Idiopathic (functional disorder) in 60% of cases
- Gastroesophageal Reflux disease (often comorbid)
- Peptic Ulcer Disease
- Biliary pain (Cholelithiasis)
- Irritable Bowel Syndrome
- Symptoms relieved by Defecation
- Associated with change in stool frequency or form
- Approach: Step 2 - Upper Endoscopy for high risk patients
- See Dyspepsia Red Flags for Indications
- Perform early upper endoscopy
- Approach: Step 3 - Consider empiric antisecretory therapy
- Timing
- Initial trial for 2-4 weeks
- Longterm antisecretory use is often needed
- General Measures
- Avoid Gastric Irritants
- Antisecretory Agents
- H2 Blocker (e.g. Ranitidine)
- Cost effective initial trial
- Switch to Proton Pump Inhibitor if not effective
- Proton Pump Inhibitor (e.g. Omeprazole)
- Highly effective agents at much higher cost
- No advantage to higher Omeprazole doses
- Meineche-Schmidt (2004) Am J Gastroenterol 99:1050
- H2 Blocker (e.g. Ranitidine)
- Adjunctive medication options
- Metoclopramide (prokinetic agent)
- May offer benefit in Nonulcer Dyspepsia
- Risk of tardive diskinesia
- Metoclopramide (prokinetic agent)
- Ineffective Medications (avoid)
- Sucralfate offers no benefit in Nonulcer Dyspepsia
- Misoprostel offers no benefit in Nonulcer Dyspepsia
- Timing
- Approach: Step 4 - Consider Helicobacter Pylori testing
- Indications
- Lack of relief with empiric antisecretory therapy
- Undifferentiated Dyspepsia
- H. pylori treatment does not benefit without ulcer
- However ulcer status unknown without endoscopy
- Test and treat strategy is cost effective
- Reserves endoscopy for Dyspepsia Red Flags
- H. pylori treatment does not benefit without ulcer
- Testing
- Protocol
- Treat with H. pylori management if positive
- Retest for cure if symptoms persist after treatment
- Indications
- Approach: Step 5 - Upper Endoscopy Indications (if not already done above)
- Incomplete relief with above management
- Approach: Step 6 - Alternative Therapies
- Selective Serotonin Reuptake Inhibitors (SSRI)
- Amitriptyline (Elavil) titrated to 30-75 mg nightly
- Hypnotherapy
- May be indicated in chronic Functional Dyspepsia
- Calvert (2002) Gastroenterology 123:1778-85
- References